glycine has been researched along with Infections, Pseudomonas in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forphenicinol did not enhance the bactericidal activity of polymorphonuclear cells (PMN) towards P." | 1.27 | Protective effect of forphenicinol, a low molecular weight immunomodifier, against infection with Pseudomonas aeruginosa in mice and its mechanisms. ( Arakawa, H; Ishizuka, M; Naito, K; Okura, A; Takeuchi, T; Umezawa, H; Watanabe, Y, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 4 (30.77) | 2.80 |
| Authors | Studies |
|---|---|
| Fraser-Pitt, DJ | 1 |
| Dolan, SK | 1 |
| Toledo-Aparicio, D | 1 |
| Hunt, JG | 1 |
| Smith, DW | 1 |
| Lacy-Roberts, N | 1 |
| Nupe Hewage, PS | 1 |
| Stoyanova, TN | 1 |
| Manson, E | 1 |
| McClean, K | 1 |
| Inglis, NF | 1 |
| Mercer, DK | 1 |
| O'Neil, DA | 1 |
| Pincus, NB | 1 |
| Rosas-Lemus, M | 1 |
| Gatesy, SWM | 1 |
| Bertucci, HK | 1 |
| Brunzelle, JS | 1 |
| Minasov, G | 1 |
| Shuvalova, LA | 1 |
| Lebrun-Corbin, M | 1 |
| Satchell, KJF | 1 |
| Ozer, EA | 1 |
| Hauser, AR | 1 |
| Bachta, KER | 1 |
| Chan, LW | 1 |
| Anahtar, MN | 1 |
| Ong, TH | 1 |
| Hern, KE | 1 |
| Kunz, RR | 1 |
| Bhatia, SN | 1 |
| Davis, EW | 1 |
| Okrent, RA | 1 |
| Manning, VA | 1 |
| Trippe, KM | 1 |
| Hagins, JM | 1 |
| Locy, R | 1 |
| Silo-Suh, L | 1 |
| Khatua, B | 1 |
| Bhattacharya, K | 1 |
| Mandal, C | 1 |
| DANIEL, W | 1 |
| PROCKL, K | 1 |
| Schultz, K | 1 |
| Mestyán, J | 1 |
| Soltész, G | 1 |
| Klujber, L | 1 |
| Dóber, I | 1 |
| Ishizuka, M | 2 |
| Masuda, T | 1 |
| Kanbayashi, N | 1 |
| Watanabe, Y | 2 |
| Matsuzaki, M | 1 |
| Sawazaki, Y | 1 |
| Ohkura, A | 1 |
| Takeuchi, T | 2 |
| Umezawa, H | 2 |
| Kudoh, I | 1 |
| Miyazaki, H | 1 |
| Yamada, H | 1 |
| Fujimoto, J | 1 |
| Ohara, M | 1 |
| Tazawa, T | 1 |
| Fukushima, J | 1 |
| Okumura, F | 1 |
| Brown, WL | 1 |
| Bowler, EG | 1 |
| Mason, AD | 1 |
| pruitt, BA | 1 |
| Naito, K | 1 |
| Arakawa, H | 1 |
| Okura, A | 1 |
| Ishibashi, T | 1 |
| Harada, Y | 1 |
| Takamoto, M | 1 |
| Shinoda, A | 1 |
13 other studies available for glycine and Infections, Pseudomonas
| Article | Year |
|---|---|
Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in
Topics: Biofilms; Cysteamine; Glycine; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence | 2021 |
Functional and Structural Characterization of OXA-935, a Novel OXA-10-Family β-Lactamase from Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aspartic Acid; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamas | 2022 |
Engineering synthetic breath biomarkers for respiratory disease.
Topics: alpha 1-Antitrypsin Deficiency; Animals; Biomarkers; Breath Tests; Computer Simulation; Dose-Respons | 2020 |
Unexpected distribution of the 4-formylaminooxyvinylglycine (FVG) biosynthetic pathway in Pseudomonas and beyond.
Topics: Anti-Bacterial Agents; Biosynthetic Pathways; Genes, Bacterial; Glycine; Herbicides; Humans; Multige | 2021 |
Isocitrate lyase supplies precursors for hydrogen cyanide production in a cystic fibrosis isolate of Pseudomonas aeruginosa.
Topics: Adaptation, Physiological; Carrier State; Cystic Fibrosis; D-Amino-Acid Oxidase; Gene Expression Reg | 2009 |
Sialoglycoproteins adsorbed by Pseudomonas aeruginosa facilitate their survival by impeding neutrophil extracellular trap through siglec-9.
Topics: Acetylcysteine; Adult; Animals; Antigens, CD; Cell Line; CHO Cells; Cricetinae; Cricetulus; Female; | 2012 |
[EXPERIENCES WITH GARMASTAN OINTMENT AS MASTITIS PREVENTIVE AGENT].
Topics: Anti-Infective Agents, Local; Female; Glycine; Humans; Mastitis; Ointments; Pregnancy; Proteus Infec | 1964 |
Metabolic effects of septicaemia in newborn and young infants with particular reference to the plasma free amino acids.
Topics: Alanine; Amino Acids; Amino Acids, Branched-Chain; Bacterial Infections; Escherichia coli Infections | 1980 |
Antitumor effect of forphenicinol, a low molecular weight immunomodifier, on murine transplantable tumors and microbial infections.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cyclophosphamide; | 1982 |
[Pretreatment of acid-induced lung injury with specific neutrophil elastase inhibitor ONO-5046 did not exasperate the subsequent bacterial lung infection by Pseudomonas aeruginosa].
Topics: Animals; Disease Models, Animal; Glycine; Hydrochloric Acid; Leukocyte Elastase; Male; Pneumonia, As | 2000 |
Protein metabolism in burned rats.
Topics: Animals; Blood Proteins; Body Weight; Burns; Glycine; Mafenide; Male; Muscles; Pseudomonas Infection | 1976 |
Protective effect of forphenicinol, a low molecular weight immunomodifier, against infection with Pseudomonas aeruginosa in mice and its mechanisms.
Topics: Adjuvants, Immunologic; Amikacin; Animals; Female; Glycine; Mice; Mice, Inbred ICR; Muramidase; Neut | 1987 |
Immunopotentiation with forphenicinol: increased resistance to Pseudomonas septicaemia in mice.
Topics: Adjuvants, Immunologic; Animals; Anti-Bacterial Agents; Blood Bactericidal Activity; Female; Glycine | 1985 |